Ohm Oncology Competitors and Similar CompaniesClear all

Ohm Oncology's competitors and similar companies include Blueprint Medicines, BeiGene, BioNTech and Achilles Therapeutics.

	Ohm Oncology Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.	Blueprint Medicines Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.	BeiGene BeiGene is a life science biotechnology company.	BioNTech BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.	Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
Founding Date	Founding Date 2015	Founding Date 2011	Founding Date 2010	Founding Date 2008	Founding Date 2016
Type	Type Private	Type Public	Type Public	Type Public	Type Private
Tags	Tags Manufacturing & Industrial biotech drug development oncology pharma	Tags Healthcare drug development life sciences oncology	Tags Healthcare biotech life sciences pharma	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech oncology pharma
Locations	Locations Austin, US HQ	Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH	Locations Cambridge, US HQ Beijing, CN Changping Qu, CN Guangzhou, CN Shanghai, CN Shanghai, CN Suzhou, CN see more	Locations Mainz, DE HQ Halle (Saale), DE Idar Oberstein, DE Marburg, DE Neuried, DE Planegg, DE Cambridge, US see more	Locations London, GB HQ Stevenage, GB
Employees	Employees 167% decrease	Employees 49515% increase	Employees 5,30051% increase	Employees 5,500	Employees 153
Valuation ($)	Valuation ($) N/A	Valuation ($) 4.2 b	Valuation ($) 20.2 b	Valuation ($) 23.7 b	Valuation ($) N/A
Twitter followers	Twitter followers N/A	Twitter followers 2.8 k	Twitter followers N/A	Twitter followers 83.5 k	Twitter followers 491
Number of tweets (last 30 days)	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 3	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 2	Number of tweets (last 30 days) 3
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 3.7	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 87	Average likes per tweet (last 30 days) 0.3
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 33.33%
Employee Rating	Employee Rating N/A	Employee Rating 4.2	Employee Rating 2.9	Employee Rating 3.3	Employee Rating 3.7
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $204m (FY, 2022)	Revenue (est.) $1.4b (FY, 2022)	Revenue (est.) €17.3b (FY, 2022)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $17.8m (FY, 2022)	Cost of goods $220.9m (FY, 2022)	Cost of goods €2.9b (FY, 2022)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $186.2m (FY, 2022)	Gross profit $1.2b (FY, 2022)	Gross profit €14.5b (FY, 2022)	Gross profit N/A
Net income	Net income N/A	Net income ($557.5m) (FY, 2022)	Net income ($2b) (FY, 2022)	Net income €9.4b (FY, 2022)	Net income ($71.2m) (FY, 2022)
Operating ⚠
Patents (US)	Patents (US) N/A	Patents (US) N/A	Patents (US) 30 (FY, 2020)	Patents (US) 45 (Oct, 2019)	Patents (US) N/A
Trademarks (US)	Trademarks (US) N/A	Trademarks (US) N/A	Trademarks (US) N/A	Trademarks (US) 8 (Oct, 2019)	Trademarks (US) 3 (May, 2021)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 1.7b	Total funding raised $ 75m	Total funding raised $ 1.4b	Total funding raised $ 138.1m